CAS Medical Systems (CAS Medical Systems) Change In Receivables : $-0.26 Mil (TTM As of Dec. 2018)

View and export this data going back to 1995. Start your Free Trial

What is CAS Medical Systems Change In Receivables?

CAS Medical Systems's change in receivables for the quarter that ended in Dec. 2018 was $0.18 Mil. It means CAS Medical Systems's Accounts Receivable declined by $0.18 Mil from Sep. 2018 to Dec. 2018 .

CAS Medical Systems's change in receivables for the fiscal year that ended in Dec. 2018 was $-0.26 Mil. It means CAS Medical Systems's Accounts Receivable increased by $0.26 Mil from Dec. 2017 to Dec. 2018 .

CAS Medical Systems's Accounts Receivable for the quarter that ended in Dec. 2018 was $3.18 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. CAS Medical Systems's Days Sales Outstanding for the three months ended in Dec. 2018 was 50.06.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. CAS Medical Systems's liquidation value for the three months ended in Dec. 2018 was $-6.95 Mil.

CAS Medical Systems Change In Receivables Historical Data

The historical data trend for CAS Medical Systems's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CAS Medical Systems Change In Receivables Chart

CAS Medical Systems Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Change In Receivables

Get a 7-Day Free Trial

-1.00

-0.45

-0.91

0.39

-0.26

CAS Medical Systems Quarterly Data
	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18
Change In Receivables	Get a 7-Day Free Trial															0.05	0.21	-0.27	-0.39	0.18

CAS Medical Systems Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.26 Mil.

CAS Medical Systems (NAS:CASM) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

CAS Medical Systems's Days Sales Outstanding for the quarter that ended in Dec. 2018 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	3.183	/	5.802	*	91
=	50.06

2. In Ben Graham's calculation of liquidation value, CAS Medical Systems's accounts receivable are only considered to be worth 75% of book value:

CAS Medical Systems's liquidation value for the quarter that ended in Dec. 2018 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3.272	-	13.113	+	0.75 * 3.183	+	0.5 * 1.012
=	-6.95

CAS Medical Systems Change In Receivables Related Terms

Thank you for viewing the detailed overview of CAS Medical Systems's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

CAS Medical Systems (CAS Medical Systems) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CAS Medical Systems Inc (NAS:CASM) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

44 East Industrial Road, Branford, CT, USA, 06405

Website

http://www.casmed.com

CAS Medical Systems Inc is a medical technology company that develops, manufactures, and markets non-invasive patient monitoring products. The company's products are the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. .

Executives

Alan Milinazzo	director	C/O ORTHOFIX INC, 10115 KINCEY AVENUE STE 250, HUNTERSVILLE NC 28078
Thomas M Patton	director, officer: President and CEO	C/O OSTEOTCH INC., 51 JAMES WAY, EATONTOWN NJ 07724
Kenneth R Weisshaar	director	875 PARK AVE APT 2D, NEW YORK NY 10021
James E Thomas	director, 10 percent owner	WOODS END ROAD, NEW CANAAN CT 06840
Thomas, Mcnerney & Partners Ii L.p.	10 percent owner	45 SOUTH 7TH STREET, SUITE 3060, Minneapolis MN 55402
Tmp Associates Ii Lp	10 percent owner	45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402
Tmp Nominee Ii, Llc	10 percent owner	45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402
Thomas, Mcnerney & Partners Ii, Llc	10 percent owner	45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402
Acuta Capital Fund, Lp	10 percent owner	1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002
James E Flynn	10 percent owner, other: Possible Member of 10% Group	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Management Company, L.p. (series C)	10 percent owner, other: Possible Member of 10% Group	345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Deerfield Mgmt L.p.	10 percent owner, other: Possible Member of 10% Group	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Special Situations Fund, L.p.	10 percent owner, other: Possible Member of 10% Group	780 3RD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Special Situations International Master Fund, L.p.	10 percent owner, other: Possible Member of 10% Group	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Lawrence Burstein	director	C/O UNITY VENTURE CAPITAL ASSOCIATES LTD, 245 FIFTH AVENUE, SUITE 1500, NEW YORK NY 10016